These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 19423549)
21. Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly. Komatsu T; Tanaka Y; Kitagawa Y; Koide N; Naiki Y; Morita N; Gotoh B; Yokochi T J Virol; 2018 Oct; 92(19):. PubMed ID: 30021903 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein. Irie T; Kiyotani K; Igarashi T; Yoshida A; Sakaguchi T J Virol; 2012 Jul; 86(13):7136-45. PubMed ID: 22532687 [TBL] [Abstract][Full Text] [Related]
23. Virus multiplication and induction of apoptosis by Sendai virus: role of the C proteins. Koyama AH; Irie H; Kato A; Nagai Y; Adachi A Microbes Infect; 2003 Apr; 5(5):373-8. PubMed ID: 12737992 [TBL] [Abstract][Full Text] [Related]
24. Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA. Sánchez-Aparicio MT; Garcin D; Rice CM; Kolakofsky D; García-Sastre A; Baum A J Gen Virol; 2017 Jun; 98(6):1282-1293. PubMed ID: 28631605 [TBL] [Abstract][Full Text] [Related]
25. Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. Takeuchi K; Komatsu T; Kitagawa Y; Sada K; Gotoh B J Virol; 2008 Oct; 82(20):10102-10. PubMed ID: 18684815 [TBL] [Abstract][Full Text] [Related]
26. Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells. Dave VP; Allan JE; Slobod KS; Smith FS; Ryan KW; Takimoto T; Power UF; Portner A; Hurwitz JL Virology; 1994 Mar; 199(2):376-83. PubMed ID: 7510085 [TBL] [Abstract][Full Text] [Related]
27. IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. Peters K; Chattopadhyay S; Sen GC J Virol; 2008 Apr; 82(7):3500-8. PubMed ID: 18216110 [TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children. Adderson E; Branum K; Sealy RE; Jones BG; Surman SL; Penkert R; Freiden P; Slobod KS; Gaur AH; Hayden RT; Allison K; Howlett N; Utech J; Allay J; Knight J; Sleep S; Meagher MM; Russell CJ; Portner A; Hurwitz JL Clin Vaccine Immunol; 2015 Mar; 22(3):298-303. PubMed ID: 25552633 [TBL] [Abstract][Full Text] [Related]
29. Antigenic diversity of human parainfluenza virus type 1 isolates and their immunological relationship with Sendai virus revealed by using monoclonal antibodies. Komada H; Kusagawa S; Orvell C; Tsurudome M; Nishio M; Bando H; Kawano M; Matsumura H; Norrby E; Ito Y J Gen Virol; 1992 Apr; 73 ( Pt 4)():875-84. PubMed ID: 1378879 [TBL] [Abstract][Full Text] [Related]
30. Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene. Shibata S; Okano S; Yonemitsu Y; Onimaru M; Sata S; Nagata-Takeshita H; Inoue M; Zhu T; Hasegawa M; Moroi Y; Furue M; Sueishi K J Immunol; 2006 Sep; 177(6):3564-76. PubMed ID: 16951315 [TBL] [Abstract][Full Text] [Related]
31. Role for the phosphoprotein P subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses. Dillon PJ; Parks GD J Virol; 2007 Oct; 81(20):11116-27. PubMed ID: 17686837 [TBL] [Abstract][Full Text] [Related]
32. A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates. Bartlett EJ; Cruz AM; Boonyaratanakornkit J; Esker J; Castaño A; Skiadopoulos MH; Collins PL; Murphy BR; Schmidt AC Vaccine; 2010 Jan; 28(3):767-79. PubMed ID: 19857454 [TBL] [Abstract][Full Text] [Related]
33. Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1. Sealy R; Jones BG; Surman SL; Hurwitz JL Vaccine; 2010 Sep; 28(41):6749-56. PubMed ID: 20682364 [TBL] [Abstract][Full Text] [Related]
34. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. Garcin D; Latorre P; Kolakofsky D J Virol; 1999 Aug; 73(8):6559-65. PubMed ID: 10400752 [TBL] [Abstract][Full Text] [Related]
35. Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy. Matsushita K; Shimada H; Ueda Y; Inoue M; Hasegawa M; Tomonaga T; Matsubara H; Nomura F World J Gastroenterol; 2014 Apr; 20(15):4316-28. PubMed ID: 24764668 [TBL] [Abstract][Full Text] [Related]
36. Sendai virus C protein limits NO production in infected RAW264.7 macrophages. Odkhuu E; Komatsu T; Koide N; Naiki Y; Takeuchi K; Tanaka Y; Tsolmongyn B; Jambalganiin U; Morita N; Yoshida T; Gotoh B; Yokochi T Innate Immun; 2018 Oct; 24(7):430-438. PubMed ID: 30189760 [TBL] [Abstract][Full Text] [Related]
37. Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus. Chattopadhyay S; Fensterl V; Zhang Y; Veleeparambil M; Yamashita M; Sen GC J Virol; 2013 Jan; 87(1):16-24. PubMed ID: 23077293 [TBL] [Abstract][Full Text] [Related]
38. The properties of recombinant Sendai virus having the P gene of Sendai virus pi strain derived from BHK cells persistently infected with Sendai virus. Nishio M; Nagata A; Yamamoto A; Tsurudome M; Ito M; Kawano M; Komada H; Ito Y Med Microbiol Immunol; 2006 Sep; 195(3):151-8. PubMed ID: 16465546 [TBL] [Abstract][Full Text] [Related]
39. Paramyxovirus mRNA editing leads to G deletions as well as insertions. Jacques JP; Hausmann S; Kolakofsky D EMBO J; 1994 Nov; 13(22):5496-503. PubMed ID: 7957115 [TBL] [Abstract][Full Text] [Related]